Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model.
Mache, Christin; Schulze, Jessica; Holland, Gudrun; Bourquain, Daniel; Gensch, Jean-Marc; Oh, Djin-Ye; Nitsche, Andreas; Dürrwald, Ralf; Laue, Michael; Wolff, Thorsten.
  • Mache C; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Schulze J; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Holland G; Advanced Light and Electron Microscopy (ZBS 4), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Bourquain D; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Gensch JM; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Oh DY; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Nitsche A; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Dürrwald R; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Laue M; Advanced Light and Electron Microscopy (ZBS 4), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.
  • Wolff T; Influenza and other Respiratory Viruses (Unit 17), Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. wolfft@rki.de.
Commun Biol ; 5(1): 1138, 2022 10 27.
Article en En | MEDLINE | ID: mdl-36302956
ABSTRACT
SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air-liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article